Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEESAW: Empagliflozin Effects on Appetite and Weight Regulation
2015-001594-40Phase 4Completed
- Sponsor
- University of Leicester
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Empagliflozin with Placebo (2 arms). Primary endpoints: Change in total PYY concentration between baseline and 24 weeks and Change in other appetite hormone concentrations. Started Jun 2020; status: completed.
02
Drugs
empagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-001594-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001594-40.